Exagen Inc - fluxo de caixa (NASDAQ:XGN)

Financials

Cash from operating activities -14.08 M-20.27 M-32.14 M-14.46 M-13.28 M-13.63 M -13.63 M Cash from investing activities -455 K-2.42 M-4.32 M-804 K-515 K-626 K -626 K Cash from financing activities -97 K64.68 M-489 K-10.63 M-663 K24.43 M 24.43 M Free cash flow -14.54 M-22.64 M-36.46 M-15.29 M-13.79 M-14.27 M -14.27 M

Notícias

KeyBanc reduz preço-alvo da Exagen devido a pressões de preços

KeyBanc cuts Exagen stock price target on pricing headwinds

Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-03-11

Canaccord reduz preço-alvo da Exagen para US$ 10 devido às margens

Exagen stock price target lowered to $10 by Canaccord on margin outlook

BTIG reduz preço-alvo da Exagen para US$ 9 devido à perspectiva de receita menor

BTIG cuts Exagen stock price target to $9 on lower revenue outlook

Ações da Exagen mantêm classificação Outperform na William Blair

Exagen stock maintains Outperform rating at William Blair

Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates

Lucro da Exagen veio abaixo das projeções por $0,01; receita menor do que estimativas

Exagen earnings missed by $0.01, revenue fell short of estimates